Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:44:30.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    An addition of Revision: v3.4.2 and a deletion of Revision: v3.4.1 were made in the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:23:01.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; there are no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:32:56.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated versioning/QC labels, including Last Update Submitted that Met QC Criteria and a new Revision: v3.4.0, with minor capitalization changes such as No FEAR Act Data.
    Difference
    0.2%
    Check dated 2026-01-28T06:31:14.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    A minor revision tag v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:18:26.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.